🔑 “Request and examine alternative pricing structures that could give pharmacies a definitive and transparent reimbursement model. Competitively evaluate your holistic pharmacy pricing on an annual basis and leverage audit and transparency rights to validate your PBM’s performance and compliance commitments.” Read the full report below.
A new interim report from the Federal Trade Commission was released recently highlighting the role that PBMs play in the prescription drug supply chain. What does this report entail, and what does it mean for payers? Learn more in this new blog from Krista Siano. Read here >> https://lnkd.in/g8HF_nVf